All News

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

< Prev | | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | .... 39 Next >

Steering Drivers In The Right Direction, “Healthy Vision™ With Dr. Val Jones” Radio Show Offers Information, Advice About Driving In The Dark

November 13, 2012

Johnson & Johnson Family of Diabetes Companies Provides Diabetes Supplies to Children in Developing Countries

November 12, 2012

New Phase 3 Findings Show STELARA® Significantly Reduced Signs And Symptoms Of Active Psoriatic Arthritis

November 12, 2012

Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression In Patients With Active Rheumatoid Arthritis

November 12, 2012

Efficacy and Safety Data from Phase 2B Trials of Janssen’s Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases

November 12, 2012

FDA Approves New 800mg PREZISTA® (darunavir) Tablet

November 09, 2012

< Prev | | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | .... 39 Next >

Employees

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.